$HWKN

HAWKINS INC (HWKN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HAWKINS INC (HWKN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. hwkn-20260813 0000046250 FALSE 0000046250 2026-08-13 2026-08-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported)

Original reporting
Published Aug 14, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$HWKN
Neutral
medium confidence
Mentioned
$HWKN
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HWKNNeutralLow
01

Why it matters

The disclosure is limited to the resignation notice and does not describe any dispute, operational impact, or new officer appointment details in the provided text.

02

Market read

Governance change headline risk, but no operational or financial catalyst is disclosed in the text provided.

03

What to watch

Traders should watch for a follow-on 8-K naming a replacement director or committee chair, which could matter for oversight and audit or compensation processes.

Relevance 6/10Novelty 5/10Timing: filed Aug 14, 2026, covering an Aug 13 resignation effective immediately

Background

The filing is an SEC Form 8-K under Item 5.02 for director/officer departure and related compensatory arrangements.

Company-level read

Ticker impact

$HWKNNeutralMedium confidence
Context

Hawkins, Inc. disclosed Yi “Faith” Tang’s resignation from its board and committees effective immediately in an 8-K Item 5.02 filing.

Expected impact

Likely limited near-term impact unless follow-on disclosures name a replacement or indicate governance risk.

Evidence & confidence

The only concrete fact is an immediate resignation not tied to disagreements; no financial guidance, deal, or enforcement action is included.

Market effects

Minimal sector read-through; this is company-specific governance turnover without operational allegations.

None indicated.

None indicated.

Counterpoint

The resignation may be routine and non-material since the company explicitly states it is not due to disagreements over operations or policies.

Key entities

  • Hawkins, Inc.

    Nasdaq-listed company filing the 8-K; disclosed board resignation effective immediately.

  • Yi “Faith” Tang

    Resigned from the board and its committees effective immediately; resignation not due to disagreements.

  • Daniel A. Louismet

    Vice President, General Counsel and Secretary who signed the 8-K.

Related articles

$HWKNMed

HAWKINS INC (HWKN): Results of Operations and Financial Condition

HAWKINS INC (HWKN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hwknex9912027-q1.htm EX-99.1 Document Exhibit 99.1 Hawkins, Inc. Reports First Quarter Fiscal 2027 Results Roseville, Minn., July 29, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027.

$INTCMedAI 8/10

Intel raises $20 billion in upsized share sale to fund foundry push

Intel raised $20 billion via an upsized share offering priced at $95 per share on Aug. 11, a 2.6% discount to the prior close, after initially targeting $15 billion, according to the company and Bloomberg. Intel plans to fund foundry expansion and raised its 2024 capex forecast to $20 billion. Shares fell over 4% on Monday.

$EVTLMed

Vertical Aerospace Q2 Earnings Call Highlights

Vertical Aerospace (EVTL) discussed Q2 progress on its VX4 eVTOL platform, including adding a second flight-test aircraft and hybrid-electric integration testing. It expects hybrid-electric flight testing in H1 2027 and VX4 type certification in 2029. Vertical announced a ~$100M financing package, had ~$134M cash as of Aug. 13, 2026, and expects cash runway into Q3 2027.

$DUKMedAI 8/10

Duke’s US$1.75 Billion AI Data Center Financing Could Be A Game Changer For Duke Energy (DUK)

Duke Energy (NYSE:DUK) completed a US$1.75 billion composite units offering in August 2026, selling 35,000,000 equity/derivative units at US$50 each, with Santander US, CIBC, RBC, Scotia Capital (USA) and TD Securities (USA) as co-lead underwriters. The funds support AI-linked data center power demand under long-term service agreements, alongside solid Q2 2026 results.

$TSNMed

Tyson Foods beef plant closures ‘devastating’ for communities | Arkansas Democrat Gazette

Tyson Foods said it will close two beef processing plants in Joslin, Illinois and Eagle Mountain, Utah, and is exploring selling its Pasco, Washington facility, citing tight cattle supply and a plan to optimize its beef network. Beef groups and officials cited impacts on producers and about 2,500 workers. Tyson expects 2026 fiscal-year beef operating losses of $500 million to $650 million; shares rose to $58.17.

$ATNMMed

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update

Actinium Pharmaceuticals (NYSE American: ATNM) said it expanded Actimab-A intellectual property with multiple newly issued US patents and additional pre-grant/allowed applications, covering uses in AML, MDS, and solid tumors, including combinations with venetoclax and CLAG-M. The company also amended its IND to add a manufacturing source and reported NYSE American listing compliance plan acceptance through Nov. 27, 2027.